Different Injection Site Maps & Intravesical Botulinum Toxin
NCT06185218 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-08-15
Summary
Botulinum toxin injection into the bladder is used in current practice in urological diseases such as overactive bladder or interstitial cystitis. As far as is known, botulinum toxin injection sites have not been clearly defined. In this study, investigators are planning to compare botulinum toxin effectiveness with different injection site maps.
Conditions
- Bladder Disease
Interventions
- OTHER
-
Intravesical Botulinum Toxin
Botulinum Toxin injections will be made into the bladder.
Sponsors & Collaborators
-
Başakşehir Çam & Sakura City Hospital
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2025-10-31
- Completion
- 2025-10-31
More Related Trials
-
A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
NCT01852058 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
NCT01767519 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)
NCT02786407 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder
NCT04186442 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00575016 ·Status: TERMINATED ·Phase: PHASE2
-
Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)
NCT02735499 ·Status: COMPLETED ·Phase: PHASE2
-
BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence
NCT03320850 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00461292 ·Status: COMPLETED ·Phase: PHASE3
-
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
NCT01852045 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients
NCT02601287 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea
NCT02010788 ·Status: COMPLETED
-
Toxin Retrospective Study
NCT03042052 ·Status: COMPLETED
-
Comparative Study Suburothelial and Trigonal Botulinum Toxin A Injection in Treatment of Interstitial Cystitis
NCT03076762 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation vs Botulinum Toxin Injections
NCT06796855 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
NCT00311376 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.
NCT00231491 ·Status: COMPLETED ·Phase: PHASE2
-
Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review
NCT01750645 ·Status: UNKNOWN
-
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder
NCT05463822 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
NCT00915525 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
NCT05141006 ·Status: COMPLETED ·Phase: PHASE2
-
Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females
NCT01042119 ·Status: COMPLETED
-
An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
NCT02161159 ·Status: COMPLETED
-
Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)
NCT03043287 ·Status: COMPLETED
-
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder
NCT03371342 ·Status: COMPLETED ·Phase: PHASE1
-
BOTOX® at the Time of Prolapse Surgery for OAB
NCT04807920 ·Status: UNKNOWN ·Phase: PHASE4